Literature DB >> 942273

Assessment of rheumatoid activity based on clinical features and blood and synovial fluid analysis.

M Farr, M J Kendall, D W Young, M J Meynell, C F Hawkins.   

Abstract

Joint inflammation in rheumatoid arthritis has been assessed, and the most useful guides to disease activity were determined by analysis of synovial fluid and blood together with the history of joint disability. The patient's own evaluation of the amount of pain suffered was the most useful clinical assessment. Differential cell count and glucose estimations were the most helpful guides in the synovial fluid, while C-reactive protein in the serum most accurately reflected disease activity. The effects of systemic steroids on these indices were studied, and the differences between seronegative and seropositive patients noted.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 942273      PMCID: PMC1006530          DOI: 10.1136/ard.35.2.163

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  25 in total

1.  A gel diffusion precipitin method for the estimation of C-reactive protein.

Authors:  R A CROCKSON
Journal:  J Clin Pathol       Date:  1963-05       Impact factor: 3.411

2.  Immunologic studies of the proteins of human synovial fluid.

Authors:  P H SCHUR; J SANDSON
Journal:  Arthritis Rheum       Date:  1963-04

3.  Numerical method of evaluating the status of rheumatoid arthritis.

Authors:  J LANSBURY
Journal:  Ann Rheum Dis       Date:  1958-03       Impact factor: 19.103

4.  Levels of serum immunoglobulins in patients with rheumatoid arthritis.

Authors:  R Marcolongo; A Carcassi; F Frullini; G Bianco; A Bravi
Journal:  Ann Rheum Dis       Date:  1967-09       Impact factor: 19.103

5.  5-nucleotidase in the serum and synovial fluid of patients with rheumatoid disease.

Authors:  M J Kendall; A M Bold; M Farr; C F Hawkins
Journal:  Lancet       Date:  1971-11       Impact factor: 79.321

6.  Measurement in rheumatoid arthritis.

Authors:  F D Hart; E C Huskisson
Journal:  Lancet       Date:  1972-01-01       Impact factor: 79.321

7.  Serum levels of IgG, IgM, and IgA in rheumatoid arthritis.

Authors:  E M Veys; H E Claessens
Journal:  Ann Rheum Dis       Date:  1968-09       Impact factor: 19.103

8.  Source and significance of 5-nucleotidase in synovial fluid.

Authors:  M Farr; M J Kendall; R Shuttleworth; M J Meynell; C F Hawkins
Journal:  Ann Rheum Dis       Date:  1973-07       Impact factor: 19.103

9.  Raised serum alkaline phosphatase in rheumatoid disease. An index of liver dysfunction?

Authors:  M J Kendall; R Cockel; J Becker; C F Hawkins
Journal:  Ann Rheum Dis       Date:  1970-09       Impact factor: 19.103

10.  Comparison of fixed interval and visual analogue scales for rating chronic pain.

Authors:  C R Joyce; D W Zutshi; V Hrubes; R M Mason
Journal:  Eur J Clin Pharmacol       Date:  1975-08-14       Impact factor: 2.953

View more
  11 in total

1.  The influence of drug therapy on serum immunoglobulin profiles in rheumatoid arthritis.

Authors:  A J Swannell; J Watkins
Journal:  Proc R Soc Med       Date:  1977

2.  Predictive value of synovial fluid analysis in estimating the efficacy of intra-articular corticosteroid injections in patients with rheumatoid arthritis.

Authors:  R Luukkainen; M Hakala; E Sajanti; H Huhtala; U Yli-Kerttula; R Hämeenkorpi
Journal:  Ann Rheum Dis       Date:  1992-07       Impact factor: 19.103

3.  Plasma and synovial fluid concentrations of sulphasalazine and two of its metabolites in rheumatoid arthritis.

Authors:  M Farr; A Brodrick; P A Bacon
Journal:  Rheumatol Int       Date:  1985       Impact factor: 2.631

4.  Correlation between synovial neopterin and inflammatory activity in rheumatoid arthritis.

Authors:  A Krause; H Protz; K M Goebel
Journal:  Ann Rheum Dis       Date:  1989-08       Impact factor: 19.103

5.  Impaired catecholaminergic signalling of B lymphocytes in patients with chronic rheumatic diseases.

Authors:  M Wahle; S Kölker; A Krause; G R Burmester; C G Baerwald
Journal:  Ann Rheum Dis       Date:  2001-05       Impact factor: 19.103

6.  C reactive protein and immunoglobulin G in synovial fluid and serum in joint disease.

Authors:  B Shine; J T Bourne; F Begum Baig; J Dacre; D V Doyle
Journal:  Ann Rheum Dis       Date:  1991-01       Impact factor: 19.103

7.  Effect of auranofin on plasma fibronectin, C reactive protein, and albumin levels in arthritic rats.

Authors:  K M Connolly; V J Stecher; D J Pruden
Journal:  Ann Rheum Dis       Date:  1988-06       Impact factor: 19.103

8.  Rheumatoid knee synovitis successfully treated with intra-articular rifamycin SV.

Authors:  I Caruso; F Montrone; M Fumagalli; C Patrono; S Santandrea; M C Gandini
Journal:  Ann Rheum Dis       Date:  1982-06       Impact factor: 19.103

9.  Discriminatory indices of response of patients with rheumatoid arthritis treated with D-penicillamine.

Authors:  J S Dixon; M E Pickup; J R Lowe; C Hallett; M R Lee; V Wright
Journal:  Ann Rheum Dis       Date:  1980-08       Impact factor: 19.103

10.  Stimulation of murine macrophage cathepsin B by serum from patients with rheumatoid arthritis: an indicator of disease activity.

Authors:  M Ostensen; B Mørland; G Husby
Journal:  Clin Exp Immunol       Date:  1983-01       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.